Dr. Hobson is a principal in LoneStar PharmTox LLC and serves as a consultant to government and industry on product and technology development issues for dermatologic, wound healing and tissue repair therapeutics. He is also the Chief Scientific Officer for nanoTox Inc., an international nanotechnology toxicological testing firm.

His former positions include: Vice President for Research and Development, Chrysalis Biotechnology; Vice President, Medical Product Research and Development, Healthpoint, Ltd.; Director of Pharmaceutical Sciences at DPT Laboratories Ltd.; Vice President and a Research Fellow at Battelle Memorial Institute; Director of Applied Toxicology, Naval Medical Research Institute. He is a past president of the American College of Toxicology and has served as a dermatotoxicology session chairperson for both the Society of Toxicology and American College of Toxicology.

He is currently the President of the Dermatotoxicology specialty section of the Society of Toxicology and is the dermatoxicology editor for the International Journal of Toxicology. He has been intimately involved in the research and development of wound healing, infection prevention, dermatological, oral and tissue repair products intended for human and veterinary use and has been involved in various aspects of pharmaceutical development including the discovery and development of medical chemical/biological warfare countermeasures for over two decades.

He holds a Bachelor of Science degree from the University of Nebraska as well as Master of Science and Doctor of Philosophy degrees from Texas A&M University. His principal fields of training and expertise are in toxicology and pharmacology.

He is a Diplomate of the American Board of Toxicology and is a member of the American College of Toxicology, Society of Toxicology, Southwestern Association of Toxicologists, Roundtable of Toxicology Consultants, Wound Healing Society, Association for Advanced Wound Care and the American Association for the Advancement of Science.

Dr. Hobson also holds adjunct faculty positions at the University of the Incarnate Word and the University of Texas at San Antonio and currently teaches courses in Biophysics, Radiation Biology, and Nuclear Pharmacy.

He has authored or co-authored several articles and book chapters on dermatoxicology, gastrointestinal toxicology, pharmacology and toxicology study design, nanomaterials safety, pharmaceutical manufacturing and product formulation, as other aspects of pharmaceutical research and development.

Dr. Hobson has over 25 years of practical experience in both participating in and directing pharmacological and toxicological research using a variety of in vitro and in vivo pre-clinical models as well as preparation of medical device submissions to regulatory agencies as well as the CMC and pharmacology/toxicology sections for, INDs and NDAs and the design and oversight of clinical studies to meet various research objectives including dermatological, infection control, wound healing, bone repair and oncology formulations. These endeavors have resulted in currently marketed pharmaceutical products and various patents.

Larry Gibbs is Associate Vice-Provost for Environmental Health and Safety at Stanford University, a position he has held since 1992, where he is responsible for all health, safety, and environmental risk management programs in addition to oversight of institutional emergency planning and risk communication.

Prior to his appointment at Stanford, he held positions with similar responsibility at Yale University, where he also served as adjunct faculty in the School of Public Health, and at the University of Connecticut. He has graduate degrees in chemistry education from Boston University and in industrial hygiene and public health from the University of Michigan.

His work at Stanford University involves health, safety and environmental management oversight of nanotechnology research centers on campus, including the Stanford Nanofabrication Facility and the Stanford Nanocharacterization Laboratory, as well as a myriad of nanotechnology research conducted in materials science and engineering and at the Stanford medical school. A major element of Mr. Gibbs work has focused on issues of risk communication regarding hazardous materials in the workplace and within the community.

Mr. Gibbs is a certified industrial hygienist with over 25 years of experience in developing, implementing and managing safety, health and environmental programs for academic, research and clinical institutions. In addition to his work at the universities, he serves as a consultant for industrial, pharmaceutical, biotechnology and government organizations.

He has authored over 25 publications on health, safety and environmental management, and co-authored two books.

Larry is active in a number of professional organizations. He is currently on the Board of Directors of the National Association of Environmental Managers (NAEM), serves on the Executive Council of the Campus Safety Health and Environmental Management Association and is active in the American Industrial Hygiene Association, where he founded the AIHA Laboratory Health and Safety Committee.

He recently was elected to the position of Chair-Elect of the American Conference of Governmental Industrial Hygienists (ACGIH) and has also served on the Board of the American Biological Safety Association.

• Professor of Engineering, Brown University, Providence, RI
• Editor, Carbon
• Member of Editorial Board for Combustion and Flame
• 2006 Program Chair for the American Chemical Society Division of Fuel
• Chemistry Technical Program Chair, Carbon2004
• Editor of Carbon special edition on Nanotoxicology
• Founding Member of Nanomaterials Safety Working Group at Brown

Professor Hurt conducts research on energy and environmental topics with special emphasis on the synthesis, structure, and application of carbon materials and nanomaterials.

• Professor of Investigative Dermatology and Toxicology, Center for Chemical Toxicology Research and Research Pharmacokinetics, North Carolina State University (NCSU), Raleigh, NC
• Research Adjunct Professor, Department of Dermatology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
• Professor, Joint Biomedical Engineering Associate Faculty, NCSU, Raleigh, NC and UNC Chapel Hill, NC
• National Society of Toxicology, Board of Publications
• Associate Editor for Nanomedicine: A Multidisciplinary Review (NAMR)
• Editorial Board for the Journal of Applied Toxicology (2000-present)
• Toxicology (2001-present)
• Editorial Board for Toxicology Mechanisms and Methods (2002-present)
• SOT Chemical/Biological Terrorism Resource Registry
• United States Environmental Protection Agency (EPA) Scientific Advisory Panel for FIFRA (2004-present)
• NIEHS, Scientific Advisory Committee on Alternative Toxicological methods (SACATM)- Advisory to ICCVAM
• HESI, ILSI Health and Environmental Sciences Institute. Nanomaterial Safety Subcommittee.
• International Life Sciences Institute (ILSI)- Risk Sciences Institute Nanomaterial Toxicity Screening Working Group.

Nancy Ann Monteiro-Riviere, Ph.D. is a Professor of Investigative Dermatology and Toxicology in the Center for Chemical Toxicology Research and Pharmacokinetics, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University (NCSU) in Raleigh NC.

She received her B.S. in Biology (cum laude) from Stonehill College in North Easton, MA and her M.S. and Ph.D. in Anatomy from Purdue University in West Lafayette, IN.

She completed post-doctoral training in Experimental Pathology / Toxicology at the Chemical Industry Institute of Toxicology in Research Triangle Park, NC.

She joined the faculty at NCSU in 1984. Dr. Monteiro-Riviere is also a Professor in the NCSU/UNC-CH Biomedical Engineering Faculty as well as being a Research Adjunct Professor in the Department of Dermatology, School of Medicine at the University of North Carolina at Chapel Hill.

She is a Fellow In the Academy of Toxicological Sciences and a founding member of American Academy of Nanomedicine.

She is a member of Sigma Xi and Phi Zeta honor societies.

Dr. Monteiro-Riviere is past president of the Dermal Toxicology Specialty Section, and past-president of the In Vitro Specialty Section of the Society of Toxicology.

Presently, she serves on the NIH Scientific Advisory Committee on Alternative Toxicological methods (SACATM), the Board of Publications of the Society of Toxicology and Editorial Boards of the Journal of Applied Toxicology, Journal of Toxicology - Cutaneous and Ocular, Toxicology In Vitro, and Toxicology Mechanisms and Methods.

Dr. Monteiro-Riviere has published more than 160 publications, holds a US patent, and has been the recipient of millions of dollars in extramural research support from various government and private sources.

Her current research interests relate to chemical absorption and mechanisms of chemical irritation to skin.

Dr. I.M.C.M. Rietjens is a Professor in Toxicology at Wageningen University in the Netherlands and engaged in research studies in the area of agrotechnology and food sciences.

Most recently, professor Rietjens has developed quantitative structure activity models using in vitro and in silico data to predict the in vivo toxicity of chlorinated alkanes to fish.

She has participated as a faculty member in the Bio-Nanotechnology, International Advanced Course, conducted by Wageningen University and has authored or co-authored numerous research articles concerned with the toxicology of food and agricultural products.

James E. Riviere, D.V.M., Ph.D. is the Burroughs Wellcome Fund Distinguished Professor of Pharmacology; Director, Center for Chemical Toxicology Research and Pharmacokinetics; and Director of the Biomathematics Program of the College of Physical and Mathematical Sciences, North Carolina State University (NCSU) in Raleigh NC.

He is an elected member of the Institute of Medicine of the National Academies and a fellow of the Academy of Toxicological Sciences.

Dr. Riviere received his BS (summa cum laude) and MS degrees from Boston College and his DVM and PhD in pharmacology from Purdue University. He is a member of Phi Beta Kappa, Phi Zeta and Sigma Xi, and has served on the Science Board of the Food and Drug Administration.

His honors include the 1999 O. Max Gardner Award from the Board of Governors of the Consolidated University of North Carolina, the 1991 Ebert Prize from the American Pharmaceutical Association, and the Harvey W. Wiley Medal and FDA Commissioner's Special Citation.

He is the Editor of the Journal of Veterinary Pharmacology and Therapeutics, and co-founder and co-director of the USDA Food Animal Residue Avoidance Databank (FARAD) program.

He is Past-President of the Dermatotoxicology Specialty Section of the Society of Toxicology and is a member of the Editorial Board of Toxicology and Applied Pharmacology as well as Skin Pharmacology and Applied Skin Physiology.

Dr. Riviere has had extramural research support from both government and industry totaling over 15 million dollars on grants he was the principal investigator. He has published over 400 full-length research papers and chapters.

He holds 5 U.S. Patents. Dr. Riviere has authored/edited 10 books in pharmacokinetics, toxicology and food safety.

His current research interests relate to applying biomathematics to problems in toxicology, including the risk assessment of chemical mixtures, pharmacokinetics, absorption of drugs and chemicals across skin, and the food safety and pharmacokinetics of tissue residues in food producing animals.

• Director, Center for Environmental & Human Toxicology, University of Florida
• Toxicology and Applied Toxicology, Editorial Board
• Human and Ecological Risk Assessment, Editorial Board
• Nonlinearity in Biology-Toxicology-Medicine, Editorial Board

Dr. Steve Roberts is Director of the Center for Environmental & Human Toxicology at the University of Florida, and is a Professor with joint appointments in the Department of Physiological Sciences in the College of Veterinary Medicine and the Department of Pharmacology and Therapeutics in the College of Medicine.

He received his Ph.D. from the University of Utah College of Medicine in 1977, and subsequently completed a National Institutes of Health (NIH) individual postdoctoral fellowship in pharmacokinetics at SUNY Buffalo.

He has previously served on the faculties of the College of Pharmacy at the University of Cincinnati and the College of Medicine at the University of Arkansas for Medical Sciences.

Dr. Roberts has an active research program funded by the NIH to examine mechanisms of toxicity, primarily involving the liver and immune system. His teaching responsibilities at the University of Florida include graduate courses in toxicology and risk assessment, as well as invited lectures in other graduate and professional courses.

Dr. Roberts serves as an advisor to the Florida Department of Environmental Protection on issues pertaining to toxicology and risk assessment.

He also serves on the committee on Bioavailability of Contaminants in Soils and Sediments for the National Research Council and on the Board of Scientific Counselors of the National Toxicology Program.